Oregon · House Bill 2103 · 2025 Regular Session

Directs the State Board of Pharmacy to adopt rules to classify xylazine as a Schedule IV controlled substance.

  1. Introduced Jan 13, 2025
  2. In committee Jan 17, 2025
  3. Died  
  4. Passed the Senate  
  5. To the governor  
  6. Became law  

What it does

The legislature's own summary of the bill, or its official long title.

The Act tells the State Board of Pharmacy to classify xylazine as a Schedule IV controlled substance. (Flesch Readability Score: 60.1). Directs the State Board of Pharmacy to adopt rules to classify xylazine as a Schedule IV controlled substance.

Every action

3 steps, oldest first, as the legislature records them.

  1. HouseFirst reading. Referred to Speaker's desk.
  2. CommitteeReferred to Behavioral Health and Health Care. · House Behavioral Health and Health Care
  3. HouseIn committee upon adjournment.

Roll calls

No recorded votes on this bill yet.

Sponsors

The member who introduced it.

From Oregon's official records (api.oregonlegislature.gov), checked Nov 13, 2026. Text links go to the official versions; LegiList does not copy bill text.